nodes	percent_of_prediction	percent_of_DWPC	metapath
Azathioprine—Nucleic Acid Synthesis Inhibitors—Cytarabine—lymphatic system cancer	0.915	1	CiPCiCtD
Azathioprine—Myelosuppression—Bleomycin—lymphatic system cancer	0.000934	0.011	CcSEcCtD
Azathioprine—Bone marrow depression—Fludarabine—lymphatic system cancer	0.000885	0.0104	CcSEcCtD
Azathioprine—Myelosuppression—Carmustine—lymphatic system cancer	0.000816	0.00956	CcSEcCtD
Azathioprine—Herpes zoster—Fludarabine—lymphatic system cancer	0.000794	0.0093	CcSEcCtD
Azathioprine—Myelosuppression—Vincristine—lymphatic system cancer	0.000779	0.00913	CcSEcCtD
Azathioprine—Myelosuppression—Mitoxantrone—lymphatic system cancer	0.000758	0.00889	CcSEcCtD
Azathioprine—Anaemia megaloblastic—Methotrexate—lymphatic system cancer	0.000752	0.00881	CcSEcCtD
Azathioprine—Interstitial pneumonia—Mitoxantrone—lymphatic system cancer	0.000736	0.00862	CcSEcCtD
Azathioprine—Interstitial lung disease—Bleomycin—lymphatic system cancer	0.000619	0.00726	CcSEcCtD
Azathioprine—Neoplasm—Teniposide—lymphatic system cancer	0.000615	0.00721	CcSEcCtD
Azathioprine—Cyst—Carmustine—lymphatic system cancer	0.000572	0.00671	CcSEcCtD
Azathioprine—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.000565	0.00662	CcSEcCtD
Azathioprine—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00055	0.00644	CcSEcCtD
Azathioprine—Bone marrow depression—Vincristine—lymphatic system cancer	0.000541	0.00634	CcSEcCtD
Azathioprine—Interstitial lung disease—Carmustine—lymphatic system cancer	0.00054	0.00633	CcSEcCtD
Azathioprine—Reaction gastrointestinal—Methotrexate—lymphatic system cancer	0.000531	0.00622	CcSEcCtD
Azathioprine—Bone marrow depression—Mitoxantrone—lymphatic system cancer	0.000527	0.00617	CcSEcCtD
Azathioprine—Lymphoma—Methotrexate—lymphatic system cancer	0.000507	0.00594	CcSEcCtD
Azathioprine—Interstitial lung disease—Mitoxantrone—lymphatic system cancer	0.000502	0.00589	CcSEcCtD
Azathioprine—Hepatotoxicity—Carmustine—lymphatic system cancer	0.000495	0.00581	CcSEcCtD
Azathioprine—Hepatic failure—Fludarabine—lymphatic system cancer	0.000483	0.00566	CcSEcCtD
Azathioprine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.000482	0.00564	CcSEcCtD
Azathioprine—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.000466	0.00546	CcSEcCtD
Azathioprine—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.000463	0.00543	CcSEcCtD
Azathioprine—Intestinal perforation—Methotrexate—lymphatic system cancer	0.000448	0.00525	CcSEcCtD
Azathioprine—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.000438	0.00513	CcSEcCtD
Azathioprine—Alopecia—Mechlorethamine—lymphatic system cancer	0.000409	0.0048	CcSEcCtD
Azathioprine—Pancytopenia—Teniposide—lymphatic system cancer	0.000405	0.00475	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.000391	0.00458	CcSEcCtD
Azathioprine—Bacterial infection—Methotrexate—lymphatic system cancer	0.000384	0.0045	CcSEcCtD
Azathioprine—Interstitial pneumonia—Methotrexate—lymphatic system cancer	0.000367	0.0043	CcSEcCtD
Azathioprine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.000361	0.00423	CcSEcCtD
Azathioprine—Pancytopenia—Fludarabine—lymphatic system cancer	0.000356	0.00417	CcSEcCtD
Azathioprine—Neoplasm—Carmustine—lymphatic system cancer	0.000346	0.00405	CcSEcCtD
Azathioprine—Haemoglobin—Teniposide—lymphatic system cancer	0.000343	0.00402	CcSEcCtD
Azathioprine—Haemorrhage—Teniposide—lymphatic system cancer	0.000341	0.004	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.000341	0.004	CcSEcCtD
Azathioprine—Pneumonia—Fludarabine—lymphatic system cancer	0.000336	0.00394	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.000331	0.00388	CcSEcCtD
Azathioprine—Infection—Mechlorethamine—lymphatic system cancer	0.000327	0.00383	CcSEcCtD
Azathioprine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.000322	0.00378	CcSEcCtD
Azathioprine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00032	0.00375	CcSEcCtD
Azathioprine—Chills—Teniposide—lymphatic system cancer	0.000306	0.00359	CcSEcCtD
Azathioprine—Arrhythmia—Teniposide—lymphatic system cancer	0.000305	0.00358	CcSEcCtD
Azathioprine—Alopecia—Teniposide—lymphatic system cancer	0.000302	0.00354	CcSEcCtD
Azathioprine—Haemoglobin—Fludarabine—lymphatic system cancer	0.000302	0.00354	CcSEcCtD
Azathioprine—Haemorrhage—Fludarabine—lymphatic system cancer	0.0003	0.00352	CcSEcCtD
Azathioprine—Hepatic failure—Vincristine—lymphatic system cancer	0.000295	0.00346	CcSEcCtD
Azathioprine—Polyp—Methotrexate—lymphatic system cancer	0.000291	0.00341	CcSEcCtD
Azathioprine—Erythema multiforme—Fludarabine—lymphatic system cancer	0.000284	0.00333	CcSEcCtD
Azathioprine—Anaemia—Teniposide—lymphatic system cancer	0.000275	0.00322	CcSEcCtD
Azathioprine—Chills—Fludarabine—lymphatic system cancer	0.000269	0.00316	CcSEcCtD
Azathioprine—Arrhythmia—Fludarabine—lymphatic system cancer	0.000268	0.00314	CcSEcCtD
Azathioprine—Leukopenia—Teniposide—lymphatic system cancer	0.000266	0.00312	CcSEcCtD
Azathioprine—Alopecia—Fludarabine—lymphatic system cancer	0.000265	0.00311	CcSEcCtD
Azathioprine—Cyst—Methotrexate—lymphatic system cancer	0.000265	0.00311	CcSEcCtD
Azathioprine—Bone marrow depression—Methotrexate—lymphatic system cancer	0.000262	0.00308	CcSEcCtD
Azathioprine—Pancytopenia—Bleomycin—lymphatic system cancer	0.000261	0.00306	CcSEcCtD
Azathioprine—Interstitial lung disease—Methotrexate—lymphatic system cancer	0.00025	0.00293	CcSEcCtD
Azathioprine—Pneumonia—Bleomycin—lymphatic system cancer	0.000247	0.00289	CcSEcCtD
Azathioprine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000242	0.00284	CcSEcCtD
Azathioprine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000242	0.00284	CcSEcCtD
Azathioprine—Anaemia—Fludarabine—lymphatic system cancer	0.000241	0.00283	CcSEcCtD
Azathioprine—Infection—Teniposide—lymphatic system cancer	0.000241	0.00282	CcSEcCtD
Azathioprine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.000238	0.00278	CcSEcCtD
Azathioprine—Malaise—Fludarabine—lymphatic system cancer	0.000236	0.00276	CcSEcCtD
Azathioprine—Herpes zoster—Methotrexate—lymphatic system cancer	0.000235	0.00276	CcSEcCtD
Azathioprine—Leukopenia—Fludarabine—lymphatic system cancer	0.000234	0.00274	CcSEcCtD
Azathioprine—Hepatotoxicity—Methotrexate—lymphatic system cancer	0.000229	0.00269	CcSEcCtD
Azathioprine—Pancytopenia—Carmustine—lymphatic system cancer	0.000228	0.00267	CcSEcCtD
Azathioprine—Hypotension—Teniposide—lymphatic system cancer	0.000227	0.00266	CcSEcCtD
Azathioprine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000225	0.00264	CcSEcCtD
Azathioprine—Arthralgia—Fludarabine—lymphatic system cancer	0.000222	0.00261	CcSEcCtD
Azathioprine—Myalgia—Fludarabine—lymphatic system cancer	0.000222	0.00261	CcSEcCtD
Azathioprine—Haemoglobin—Bleomycin—lymphatic system cancer	0.000221	0.00259	CcSEcCtD
Azathioprine—Haemorrhage—Bleomycin—lymphatic system cancer	0.00022	0.00258	CcSEcCtD
Azathioprine—Discomfort—Fludarabine—lymphatic system cancer	0.00022	0.00258	CcSEcCtD
Azathioprine—Pancytopenia—Vincristine—lymphatic system cancer	0.000218	0.00255	CcSEcCtD
Azathioprine—Pneumonia—Carmustine—lymphatic system cancer	0.000215	0.00252	CcSEcCtD
Azathioprine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000212	0.00248	CcSEcCtD
Azathioprine—Infection—Fludarabine—lymphatic system cancer	0.000212	0.00248	CcSEcCtD
Azathioprine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000209	0.00245	CcSEcCtD
Azathioprine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000209	0.00245	CcSEcCtD
Azathioprine—Rash—Mechlorethamine—lymphatic system cancer	0.000207	0.00243	CcSEcCtD
Azathioprine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000207	0.00243	CcSEcCtD
Azathioprine—Pneumonia—Vincristine—lymphatic system cancer	0.000205	0.00241	CcSEcCtD
Azathioprine—Pneumonia—Mitoxantrone—lymphatic system cancer	0.0002	0.00234	CcSEcCtD
Azathioprine—Feeling abnormal—Teniposide—lymphatic system cancer	0.0002	0.00234	CcSEcCtD
Azathioprine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000198	0.00233	CcSEcCtD
Azathioprine—Chills—Bleomycin—lymphatic system cancer	0.000197	0.00231	CcSEcCtD
Azathioprine—Nausea—Mechlorethamine—lymphatic system cancer	0.000195	0.00229	CcSEcCtD
Azathioprine—Alopecia—Bleomycin—lymphatic system cancer	0.000194	0.00228	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000194	0.00228	CcSEcCtD
Azathioprine—Haemoglobin—Carmustine—lymphatic system cancer	0.000193	0.00226	CcSEcCtD
Azathioprine—Haemorrhage—Carmustine—lymphatic system cancer	0.000192	0.00225	CcSEcCtD
Azathioprine—Abdominal pain—Teniposide—lymphatic system cancer	0.000192	0.00225	CcSEcCtD
Azathioprine—Body temperature increased—Teniposide—lymphatic system cancer	0.000192	0.00225	CcSEcCtD
Azathioprine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000186	0.00218	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000184	0.00216	CcSEcCtD
Azathioprine—Vasculitis—Methotrexate—lymphatic system cancer	0.000182	0.00213	CcSEcCtD
Azathioprine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000179	0.0021	CcSEcCtD
Azathioprine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000179	0.00209	CcSEcCtD
Azathioprine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000179	0.00209	CcSEcCtD
Azathioprine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000178	0.00208	CcSEcCtD
Azathioprine—Anaemia—Bleomycin—lymphatic system cancer	0.000177	0.00208	CcSEcCtD
Azathioprine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000176	0.00206	CcSEcCtD
Azathioprine—Malaise—Bleomycin—lymphatic system cancer	0.000173	0.00202	CcSEcCtD
Azathioprine—Arrhythmia—Carmustine—lymphatic system cancer	0.000172	0.00201	CcSEcCtD
Azathioprine—Leukopenia—Bleomycin—lymphatic system cancer	0.000171	0.00201	CcSEcCtD
Azathioprine—Alopecia—Carmustine—lymphatic system cancer	0.00017	0.00199	CcSEcCtD
Azathioprine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000169	0.00198	CcSEcCtD
Azathioprine—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000166	0.00195	CcSEcCtD
Azathioprine—Diarrhoea—Teniposide—lymphatic system cancer	0.000166	0.00195	CcSEcCtD
Azathioprine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000165	0.00194	CcSEcCtD
Azathioprine—Myalgia—Bleomycin—lymphatic system cancer	0.000163	0.00191	CcSEcCtD
Azathioprine—Alopecia—Vincristine—lymphatic system cancer	0.000162	0.0019	CcSEcCtD
Azathioprine—Discomfort—Bleomycin—lymphatic system cancer	0.000161	0.00189	CcSEcCtD
Azathioprine—Chills—Mitoxantrone—lymphatic system cancer	0.00016	0.00188	CcSEcCtD
Azathioprine—Neoplasm—Methotrexate—lymphatic system cancer	0.00016	0.00188	CcSEcCtD
Azathioprine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00016	0.00187	CcSEcCtD
Azathioprine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000158	0.00185	CcSEcCtD
Azathioprine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000157	0.00184	CcSEcCtD
Azathioprine—Infection—Bleomycin—lymphatic system cancer	0.000155	0.00182	CcSEcCtD
Azathioprine—Anaemia—Carmustine—lymphatic system cancer	0.000155	0.00181	CcSEcCtD
Azathioprine—Vomiting—Teniposide—lymphatic system cancer	0.000154	0.00181	CcSEcCtD
Azathioprine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000153	0.00179	CcSEcCtD
Azathioprine—Rash—Teniposide—lymphatic system cancer	0.000153	0.00179	CcSEcCtD
Azathioprine—Dermatitis—Teniposide—lymphatic system cancer	0.000153	0.00179	CcSEcCtD
Azathioprine—Headache—Teniposide—lymphatic system cancer	0.000152	0.00178	CcSEcCtD
Azathioprine—Leukopenia—Carmustine—lymphatic system cancer	0.00015	0.00175	CcSEcCtD
Azathioprine—Anaemia—Vincristine—lymphatic system cancer	0.000148	0.00173	CcSEcCtD
Azathioprine—Hypotension—Bleomycin—lymphatic system cancer	0.000146	0.00171	CcSEcCtD
Azathioprine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000146	0.00171	CcSEcCtD
Azathioprine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000144	0.00169	CcSEcCtD
Azathioprine—Nausea—Teniposide—lymphatic system cancer	0.000144	0.00169	CcSEcCtD
Azathioprine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000144	0.00168	CcSEcCtD
Azathioprine—Hepatic failure—Methotrexate—lymphatic system cancer	0.000143	0.00168	CcSEcCtD
Azathioprine—Leukopenia—Vincristine—lymphatic system cancer	0.000143	0.00167	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000142	0.00167	CcSEcCtD
Azathioprine—Myalgia—Carmustine—lymphatic system cancer	0.000142	0.00167	CcSEcCtD
Azathioprine—Malaise—Mitoxantrone—lymphatic system cancer	0.00014	0.00164	CcSEcCtD
Azathioprine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000139	0.00163	CcSEcCtD
Azathioprine—Myalgia—Vincristine—lymphatic system cancer	0.000136	0.00159	CcSEcCtD
Azathioprine—Infection—Carmustine—lymphatic system cancer	0.000136	0.00159	CcSEcCtD
Azathioprine—Vomiting—Fludarabine—lymphatic system cancer	0.000136	0.00159	CcSEcCtD
Azathioprine—Rash—Fludarabine—lymphatic system cancer	0.000134	0.00158	CcSEcCtD
Azathioprine—Dermatitis—Fludarabine—lymphatic system cancer	0.000134	0.00157	CcSEcCtD
Azathioprine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000134	0.00157	CcSEcCtD
Azathioprine—Headache—Fludarabine—lymphatic system cancer	0.000134	0.00157	CcSEcCtD
Azathioprine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000132	0.00155	CcSEcCtD
Azathioprine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000132	0.00155	CcSEcCtD
Azathioprine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000131	0.00153	CcSEcCtD
Azathioprine—Infection—Vincristine—lymphatic system cancer	0.000129	0.00152	CcSEcCtD
Azathioprine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000129	0.00151	CcSEcCtD
Azathioprine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000128	0.00149	CcSEcCtD
Azathioprine—Hypotension—Carmustine—lymphatic system cancer	0.000128	0.00149	CcSEcCtD
Azathioprine—Nausea—Fludarabine—lymphatic system cancer	0.000127	0.00148	CcSEcCtD
Azathioprine—Infection—Mitoxantrone—lymphatic system cancer	0.000126	0.00148	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000124	0.00146	CcSEcCtD
Azathioprine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000124	0.00146	CcSEcCtD
Azathioprine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000124	0.00145	CcSEcCtD
Azathioprine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000123	0.00144	CcSEcCtD
Azathioprine—Hypotension—Vincristine—lymphatic system cancer	0.000122	0.00143	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000119	0.00139	CcSEcCtD
Azathioprine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000119	0.00139	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000118	0.00138	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000116	0.00136	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000116	0.00135	CcSEcCtD
Azathioprine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000115	0.00135	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000112	0.00132	CcSEcCtD
Azathioprine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000112	0.00132	CcSEcCtD
Azathioprine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000112	0.00131	CcSEcCtD
Azathioprine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000109	0.00128	CcSEcCtD
Azathioprine—Body temperature increased—Carmustine—lymphatic system cancer	0.000108	0.00126	CcSEcCtD
Azathioprine—Abdominal pain—Carmustine—lymphatic system cancer	0.000108	0.00126	CcSEcCtD
Azathioprine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000107	0.00125	CcSEcCtD
Azathioprine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000107	0.00125	CcSEcCtD
Azathioprine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000106	0.00124	CcSEcCtD
Azathioprine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000105	0.00123	CcSEcCtD
Azathioprine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000104	0.00122	CcSEcCtD
Azathioprine—Body temperature increased—Vincristine—lymphatic system cancer	0.000103	0.00121	CcSEcCtD
Azathioprine—Abdominal pain—Vincristine—lymphatic system cancer	0.000103	0.00121	CcSEcCtD
Azathioprine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000101	0.00118	CcSEcCtD
Azathioprine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.0001	0.00118	CcSEcCtD
Azathioprine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0001	0.00118	CcSEcCtD
Azathioprine—Pneumonia—Methotrexate—lymphatic system cancer	9.97e-05	0.00117	CcSEcCtD
Azathioprine—Vomiting—Bleomycin—lymphatic system cancer	9.94e-05	0.00117	CcSEcCtD
Azathioprine—Infestation NOS—Methotrexate—lymphatic system cancer	9.91e-05	0.00116	CcSEcCtD
Azathioprine—Infestation—Methotrexate—lymphatic system cancer	9.91e-05	0.00116	CcSEcCtD
Azathioprine—Rash—Bleomycin—lymphatic system cancer	9.86e-05	0.00116	CcSEcCtD
Azathioprine—Dermatitis—Bleomycin—lymphatic system cancer	9.85e-05	0.00115	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	9.83e-05	0.00115	CcSEcCtD
Azathioprine—Hypersensitivity—Vincristine—lymphatic system cancer	9.6e-05	0.00112	CcSEcCtD
Azathioprine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	9.37e-05	0.0011	CcSEcCtD
Azathioprine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	9.35e-05	0.0011	CcSEcCtD
Azathioprine—Diarrhoea—Carmustine—lymphatic system cancer	9.34e-05	0.00109	CcSEcCtD
Azathioprine—Nausea—Bleomycin—lymphatic system cancer	9.29e-05	0.00109	CcSEcCtD
Azathioprine—Agranulocytosis—Methotrexate—lymphatic system cancer	9.25e-05	0.00108	CcSEcCtD
Azathioprine—Dizziness—Carmustine—lymphatic system cancer	9.02e-05	0.00106	CcSEcCtD
Azathioprine—Haemoglobin—Methotrexate—lymphatic system cancer	8.94e-05	0.00105	CcSEcCtD
Azathioprine—Diarrhoea—Vincristine—lymphatic system cancer	8.91e-05	0.00104	CcSEcCtD
Azathioprine—Haemorrhage—Methotrexate—lymphatic system cancer	8.9e-05	0.00104	CcSEcCtD
Azathioprine—Diarrhoea—Mitoxantrone—lymphatic system cancer	8.68e-05	0.00102	CcSEcCtD
Azathioprine—Vomiting—Carmustine—lymphatic system cancer	8.68e-05	0.00102	CcSEcCtD
Azathioprine—Dizziness—Vincristine—lymphatic system cancer	8.61e-05	0.00101	CcSEcCtD
Azathioprine—Rash—Carmustine—lymphatic system cancer	8.6e-05	0.00101	CcSEcCtD
Azathioprine—Dermatitis—Carmustine—lymphatic system cancer	8.6e-05	0.00101	CcSEcCtD
Azathioprine—Headache—Carmustine—lymphatic system cancer	8.55e-05	0.001	CcSEcCtD
Azathioprine—Erythema multiforme—Methotrexate—lymphatic system cancer	8.41e-05	0.000986	CcSEcCtD
Azathioprine—Vomiting—Vincristine—lymphatic system cancer	8.28e-05	0.000971	CcSEcCtD
Azathioprine—Rash—Vincristine—lymphatic system cancer	8.21e-05	0.000963	CcSEcCtD
Azathioprine—Dermatitis—Vincristine—lymphatic system cancer	8.21e-05	0.000962	CcSEcCtD
Azathioprine—Headache—Vincristine—lymphatic system cancer	8.16e-05	0.000956	CcSEcCtD
Azathioprine—Nausea—Carmustine—lymphatic system cancer	8.11e-05	0.00095	CcSEcCtD
Azathioprine—Vomiting—Mitoxantrone—lymphatic system cancer	8.07e-05	0.000945	CcSEcCtD
Azathioprine—Immune system disorder—Methotrexate—lymphatic system cancer	8.04e-05	0.000942	CcSEcCtD
Azathioprine—Mediastinal disorder—Methotrexate—lymphatic system cancer	8.02e-05	0.00094	CcSEcCtD
Azathioprine—Rash—Mitoxantrone—lymphatic system cancer	8e-05	0.000938	CcSEcCtD
Azathioprine—Dermatitis—Mitoxantrone—lymphatic system cancer	7.99e-05	0.000937	CcSEcCtD
Azathioprine—Chills—Methotrexate—lymphatic system cancer	7.98e-05	0.000936	CcSEcCtD
Azathioprine—Headache—Mitoxantrone—lymphatic system cancer	7.95e-05	0.000932	CcSEcCtD
Azathioprine—Alopecia—Methotrexate—lymphatic system cancer	7.86e-05	0.000921	CcSEcCtD
Azathioprine—Nausea—Vincristine—lymphatic system cancer	7.74e-05	0.000907	CcSEcCtD
Azathioprine—Nausea—Mitoxantrone—lymphatic system cancer	7.54e-05	0.000883	CcSEcCtD
Azathioprine—Ill-defined disorder—Methotrexate—lymphatic system cancer	7.19e-05	0.000842	CcSEcCtD
Azathioprine—Anaemia—Methotrexate—lymphatic system cancer	7.16e-05	0.000839	CcSEcCtD
Azathioprine—Malaise—Methotrexate—lymphatic system cancer	6.98e-05	0.000819	CcSEcCtD
Azathioprine—Leukopenia—Methotrexate—lymphatic system cancer	6.93e-05	0.000813	CcSEcCtD
Azathioprine—Myalgia—Methotrexate—lymphatic system cancer	6.59e-05	0.000773	CcSEcCtD
Azathioprine—Arthralgia—Methotrexate—lymphatic system cancer	6.59e-05	0.000773	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	6.55e-05	0.000767	CcSEcCtD
Azathioprine—Discomfort—Methotrexate—lymphatic system cancer	6.51e-05	0.000764	CcSEcCtD
Azathioprine—Infection—Methotrexate—lymphatic system cancer	6.28e-05	0.000736	CcSEcCtD
Azathioprine—Thrombocytopenia—Methotrexate—lymphatic system cancer	6.19e-05	0.000725	CcSEcCtD
Azathioprine—Skin disorder—Methotrexate—lymphatic system cancer	6.14e-05	0.00072	CcSEcCtD
Azathioprine—Hypotension—Methotrexate—lymphatic system cancer	5.91e-05	0.000692	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	5.76e-05	0.000675	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	5.46e-05	0.00064	CcSEcCtD
Azathioprine—Feeling abnormal—Methotrexate—lymphatic system cancer	5.21e-05	0.00061	CcSEcCtD
Azathioprine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	5.17e-05	0.000606	CcSEcCtD
Azathioprine—Abdominal pain—Methotrexate—lymphatic system cancer	5e-05	0.000586	CcSEcCtD
Azathioprine—Body temperature increased—Methotrexate—lymphatic system cancer	5e-05	0.000586	CcSEcCtD
Azathioprine—Hypersensitivity—Methotrexate—lymphatic system cancer	4.66e-05	0.000546	CcSEcCtD
Azathioprine—Diarrhoea—Methotrexate—lymphatic system cancer	4.32e-05	0.000507	CcSEcCtD
Azathioprine—Dizziness—Methotrexate—lymphatic system cancer	4.18e-05	0.00049	CcSEcCtD
Azathioprine—Vomiting—Methotrexate—lymphatic system cancer	4.02e-05	0.000471	CcSEcCtD
Azathioprine—Rash—Methotrexate—lymphatic system cancer	3.99e-05	0.000467	CcSEcCtD
Azathioprine—Dermatitis—Methotrexate—lymphatic system cancer	3.98e-05	0.000467	CcSEcCtD
Azathioprine—Headache—Methotrexate—lymphatic system cancer	3.96e-05	0.000464	CcSEcCtD
Azathioprine—Nausea—Methotrexate—lymphatic system cancer	3.75e-05	0.00044	CcSEcCtD
